{
    "laboratory_examinations": [
        {
            "procedure_name": "Hypokalemia Assessment",
            "date": "Not specified",
            "findings": "Marked hypokalemia (1.9-2.2 mmol/L)",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "UFC (Urine Free Cortisol)",
            "date": "Not specified",
            "findings": "53 times above the ULN",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Plasma ACTH (p-ACTH)",
            "date": "Not specified",
            "findings": "68-72 pmol/L (ref. <10 pmol/L)",
            "changes_over_time": "After surgery, p-ACTH transiently decreased to 11 pmol/L, then rapidly increased to 43000 pmol/L after 10 months."
        },
        {
            "procedure_name": "S-Cortisol",
            "date": "Not specified",
            "findings": "42 nmol/L after surgery",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "MMR and MSI Analysis",
            "date": "Not specified",
            "findings": "Loss of MSH2 and MSH6, retention of MLH1 and PMS2; classified as MSI-low.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "CT Scan",
            "date": "Not specified",
            "findings": "Showed multiple liver metastases.",
            "changes_over_time": "Confirmed pituitary origin after biopsy."
        },
        {
            "procedure_name": "Temozolomide CT",
            "date": "Not specified",
            "findings": "â‰¥ 50% regression of liver metastases.",
            "changes_over_time": "After 6 months on temozolomide, there was a progression of the liver metastases."
        }
    ]
}